Effectiveness of a cluster-randomized controlled trial community-based lifestyle intervention program to control prehypertension and/or prediabetes in Thailand

  • Supa Pengpid
  • Karl PeltzerEmail author
  • Apa Puckpinyo
  • Isareethika Jayasvasti Chantarasongsuk
Original Article


Lifestyle intervention is recommended as the primary management for prehypertension and prediabetes. The aim of the study was to examine the effect of a community-based lifestyle intervention on glucose and blood pressure levels in Nakhon Pathom Province, Thailand. We conducted a cluster-randomized community trial in 12 Buddhist temples, enrolling 443 members, aged 35–65 years, with prediabetes and/or prehypertension. The temple (and their members) was randomized to six 2-h group session of lifestyle intervention (physical activity and nutrition) over 6 months guided by the Health Action Process Approach model or receiving a healthy lifestyle pamphlet. Physical outcomes (glucose, blood pressure, lipid profiles, and anthropometric measures) were assessed at 6 and/or 12 months following baseline assessments. The effects of the lifestyle intervention were assessed with generalized linear mixed models. The study recruited 443 participants in 12 temples (220 in the intervention and 223 in the control group), and 89% completed the 12-month evaluation. At 12-month follow-up, mixed modeling found significant interaction effects on fasting plasma glucose (p = 0.017) and diastolic blood pressure (p = 0.002). Improvements were found for systolic blood pressure, but no significant interaction effect was detected. In conclusion, the lifestyle intervention was only partially effective. More research is needed to investigate lifestyle interventions in this community-based setting. Trial registration number: TCTR20170721001


Community-based intervention Lifestyle intervention Prediabetes Prehypertension Thailand 



Brian Oldenburg and Pilvikki Absetz are thanked for their contribution to the design of this study.

Author contribution

Supa Pengpid and Karl Peltzer contributed to the design of the experiment, data analysis, and writing of the manuscript.

Funding information

The project was supported by the National Research Council of Thailand.

Compliance with ethical standards

Ethical considerations

The study was performed according to the principles of the Declaration of Helsinki. It was reviewed and approved by the Committee for Research Ethics (Social Sciences), Mahidol University (MU-SSIRB: 2016/053-B1). Written informed consent was obtained from all participants.


  1. 1.
    Aekplakorn W, Chariyalertsak S, Kessomboon P, Sangthong R, Inthawong R, Putwatana P, et al. Prevalence and management of diabetes and metabolic risk factors in Thai adults: the Thai National Health Examination Survey IV, 2009. Diabetes Care. 2011;34(9):1980–5.CrossRefGoogle Scholar
  2. 2.
    Aekplakorn W, Sangthong R, Kessomboon P, Putwatana P, Inthawong R, Taneepanichskul S, et al. Changes in prevalence, awareness, treatment and control of hypertension in Thai population, 2004-2009: Thai National Health Examination Survey III-IV. J Hypertens. 2012;30(9):1734–42.CrossRefGoogle Scholar
  3. 3.
    Nathan DM, Meigs J, Singer DE. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it? Lancet. 1997;350(Suppl 1):SI4–9.CrossRefGoogle Scholar
  4. 4.
    Dagogo-Jack S, Egbuonu N, Edeoga C. Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk. Med Princ Pract. 2010;19(3):167–75.CrossRefGoogle Scholar
  5. 5.
    Hedayati SS, Elsayed EF, Reilly RF. Non-pharmacological aspects of blood pressure management: what are the data? Kidney Int. 2011;79(10):1061–70.CrossRefGoogle Scholar
  6. 6.
    Lien LF, Brown AJ, Ard JD, Loria C, Erlinger TP, Feldstein AC, et al. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension. 2007;50(4):609–16.CrossRefGoogle Scholar
  7. 7.
    Lindström J, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2012;56(2):284–93. Scholar
  8. 8.
    Márquez-Celedonio FG, Téxon-Fernández O, Chávez-Negrete A, Hernández-López S, Marín-Rendón S, Berlín-Lascurain S. Clinical effect of lifestyle modification on cardiovascular risk in prehypertensives: PREHIPER I study. Rev Esp Cardiol. 2009;62(1):86–90.CrossRefGoogle Scholar
  9. 9.
    Yoon U, Kwok LL, Magkidis A. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism. 2012;62(2):303–14.CrossRefGoogle Scholar
  10. 10.
    Glasgow RE, Lichtenstein E, Marcus AC. Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health. 2003;93(8):1261–7.CrossRefGoogle Scholar
  11. 11.
    Lancaster KJ, Schoenthaler AM, Midberry SA, Watts SO, Nulty MR, Cole HV, et al. Rationale and design of Faith-based Approaches in the Treatment of Hypertension (FAITH), a lifestyle intervention targeting blood pressure control among black church members. Am Heart J. 2014;167(3):301–7.CrossRefGoogle Scholar
  12. 12.
    Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med. 2008;35(4):357–63.CrossRefGoogle Scholar
  13. 13.
    Boltri JM, Davis-Smith M, Okosun IS, Seale JP, Foster B. Translation of the national institutes of health diabetes prevention program in African American churches. J Natl Med Assoc. 2011;103(3):194–202.CrossRefGoogle Scholar
  14. 14.
    Oexmann MJ, Thomas JC, Taylor KB, O’Neil PM, Garvey WT, Lackland DT, et al. Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans. Ethn Dis. 2000;10(1):17–23.Google Scholar
  15. 15.
    Sattin RW, Williams LB, Dias J, Garvin JT, Marion L, Joshua TV, et al. Community trial of a faith-based lifestyle intervention to prevent diabetes among African-Americans. J Community Health. 2016;41(1):87–96.CrossRefGoogle Scholar
  16. 16.
    Hathirat S. Buddhist monks as community health workers in Thailand. Soc Sci Med. 1983;17(19):1485–7.CrossRefGoogle Scholar
  17. 17.
    Narkpong Y. Satisfaction of elderly to senior services center for older persons in community: a case study in senior services center, Suwandararam temple, Ayutthaya Province. Unpublished M.A. thesis (population studies): Faculty of Graduate Studies, Mahidol University; 2000.Google Scholar
  18. 18.
    Sasiwongsaroj K, Pornsiripongse S, Burasith Y, Ketjamnong P, Koosakulrat N. Buddhist temple: the well-being space for the aged in Thailand. JPSS. 2012;20(2):2–19.Google Scholar
  19. 19.
    Stewart O, Yamarat K, Neeser KJ, Lertmaharit S, Holroyd E. Buddhist religious practices and blood pressure among elderly in rural Uttaradit Province, Northern Thailand. Nurs Health Sci. 2014;16(1):119–25.CrossRefGoogle Scholar
  20. 20.
    Treerutkuarkul A. Thailand’s unsung heroes. Bull World Health Organ. 2008;86(1):5–6.CrossRefGoogle Scholar
  21. 21.
    Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010;7(3):e1000251.CrossRefGoogle Scholar
  22. 22.
    Thai Hypertension Society. Guidelines in the treatment of hypertension, 2013. Accessed April 1, 2016.
  23. 23.
    Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care. 2006;29(8):1872–7.CrossRefGoogle Scholar
  24. 24.
    Lee RD, Nieman DC. Nutritional assessment. Oxford: Brown & Benchmark; 1993.Google Scholar
  25. 25.
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.CrossRefGoogle Scholar
  26. 26.
    Lotrakul M, Sumrithe S, Saipanish R. Reliability and validity of the Thai version of the PHQ-9. BMC Psychiatry. 2008;8:46.CrossRefGoogle Scholar
  27. 27.
    World Health Organization (WHO) (2017). WHO STEPS instrument. (Accessed 10 September 2017).
  28. 28.
    Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.CrossRefGoogle Scholar
  29. 29.
    Lapham SC, Brown P, Suriyawongpaisal P, Skipper BJ, Chadbunchachai W, Paisarnsilp S. Use of AUDIT for alcohol screening among emergency room patients in Thailand. Alcohol Use Disorders Identification Test. Subst Use Misuse. 1999;34(13):1881–95.CrossRefGoogle Scholar
  30. 30.
    Funk KL, Elmer PJ, Stevens VJ, Harsha DW, Craddick SR, Lin PH, et al. PREMIER—a trial of lifestyle interventions for blood pressure control: intervention design and rationale. Health Promot Pract. 2008;9(3):271–80.CrossRefGoogle Scholar
  31. 31.
    Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.CrossRefGoogle Scholar
  32. 32.
    Schwarzer R, Fuchs R. Changing risk behaviors and adopting health behaviors: the role of self-efficacy beliefs. In: Bandura A, editor. Self-efficacy in changing societies. New York: Cambridge University Press; 1995. p. 259–88.CrossRefGoogle Scholar
  33. 33.
    Oettingen G, Hönig G, Gollwitzer PM. Effective self-regulation of goal attainment. Intern J Educ Res. 2000;33:705–32.CrossRefGoogle Scholar
  34. 34.
    Uutela A, Absetz P, Valve R, Talja M, Fogelholm M, Nissinen A. Health psychological theory in promoting population health in Päijät-Häme, Finland: first steps toward a type 2 diabetes prevention study. J Health Psychol. 2004;9(1):73–84.CrossRefGoogle Scholar
  35. 35.
    Absetz P. GOAL lifestyle implementation trial for the prevention of type 2 diabetes, 2007.; Accessed 10 Sept 2017.
  36. 36.
    Pengpid S, Peltzer K, Skaal L. Efficacy of a church-based lifestyle intervention programme to control high normal blood pressure and/or high normal blood glucose in church members: a randomized controlled trial in Pretoria, South Africa. BMC Public Health. 2014;14:568.CrossRefGoogle Scholar
  37. 37.
    Petrella RJ, Aizawa K, Shoemaker K, Overend T, Piche L, Marin M, et al. Efficacy of a family practice-based lifestyle intervention program to increase physical activity and reduce clinical and physiological markers of vascular health in patients with high normal blood pressure and/or high normal blood glucose (SNAC): study protocol for a randomized controlled trial. Trials. 2011;12:45.CrossRefGoogle Scholar
  38. 38.
    Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol. 2004;57(8):785–94.CrossRefGoogle Scholar
  39. 39.
    Wang Q, Chair SY, Wong EM. The effects of a lifestyle intervention program on physical outcomes, depression, and quality of life in adults with metabolic syndrome: a randomized clinical trial. Int J Cardiol. 2017;230:461–7.CrossRefGoogle Scholar
  40. 40.
    Tran VD, James AP, Lee AH, Jancey J, Howat PA, Thi Phuong Mai L. Effectiveness of a community-based physical activity and nutrition behavior intervention on features of the metabolic syndrome: a cluster-randomized controlled trial. Metab Syndr Relat Disord. 2017;15(2):63–71.CrossRefGoogle Scholar
  41. 41.
    Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002;136(7):493–503.CrossRefGoogle Scholar
  42. 42.
    Pongwecharak J, Tarakamon T. Lifestyle changes for prehypertension with other cardiovascular risk factors: findings from Thailand. J Am Pharm Assoc. 2011;51:719–26.CrossRefGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2018

Authors and Affiliations

  1. 1.ASEAN Institute for Health DevelopmentMahidol UniversitySalayaThailand
  2. 2.Department of Research Development and InnovationUniversity of LimpopoPolokwaneSouth Africa
  3. 3.Department for Management of Science and Technology DevelopmentTon Duc Thang UniversityHo Chi Minh CityVietnam
  4. 4.Faculty of PharmacyTon Duc Thang UniversityHo Chi Minh CityVietnam

Personalised recommendations